Menu

Blog

Mar 13, 2024

‘GPS nanoparticle’ platform precisely delivers therapeutic payload to cancer cells

Posted by in categories: biotech/medical, genetics, nanotechnology

A newly developed “GPS nanoparticle” injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State. They tested their approach in human cell lines and in mice to effectively knock down a cancer-causing gene, reporting that the technique may potentially offer a more precise and effective treatment for notoriously hard-to-treat basal-like breast cancers.

Comments are closed.